And, in neuroblastoma lines, NCYM knockdown decreased both Oct4 expression and MYCN binding to a known “E-box” enhancer element that drives Oct4 expression (Kaneko et al. 2015), suggesting that it regulates Oct4 via MYCN. Here, MYCN is linked to neuroblastoma.